News

Blog y noticias

Blog-amsterdam-ecvo-3-1200x675.png
07/Oct/2024

Glaucoma in animals is a chronic eye disease that affects both dogs and cats, among other species. It is usually characterized by an increase in intraocular pressure (IOP), which damages the optic nerve and retina, leading to progressive loss of vision and even blindness. As intraocular fluid, known as aqueous humor, accumulates due to a failure of its natural drainage, the pressure inside the eye increases, causing irreversible damage to the internal ocular structures.

The importance of the optic nerve and aqueous humor

The optic nerve is essential in the visual process, since it is responsible for transmitting the images captured by the retina to the brain, where they are processed to generate vision. This nerve is very sensitive to changes in pressure inside the eye. The aqueous humor, on the other hand, is a liquid that flows continuously inside the eye, providing nutrients to the internal ocular structures and eliminating waste. Under normal conditions, this fluid is drained through a specialized system in the iridocorneal angle, but in cases of glaucoma, this outflow is blocked or reduced, causing an accumulation of fluid that raises eye pressure.

There are two main types of glaucoma: primary glaucoma and secondary glaucoma. Primary glaucoma is related to genetic and anatomical causes, being more frequent in predisposed breeds of dogs, such as Cocker Spaniel or Maltese Bichon. Secondary glaucoma, on the other hand, arises as a consequence of other ocular diseases or trauma, such as chronic uveitis, lens dislocation or cataracts. The latter type is more common in cats.

Symptoms of glaucoma in animals

Glaucoma is a difficult disease to detect in its early stages, as animals usually adapt to the gradual loss of vision without showing obvious symptoms. However, as the disease progresses, clinical signs become more evident. Symptoms of glaucoma include:

  • Red eyes
  • Severe eye pain, causing the animal to rub its eyes or avoid light.
  • Dilated pupils that do not respond adequately to light
  • Blurred vision
  • Nausea, vomiting, irritability and behavioral changes due to pain
  • Cloudy appearance or bluish halo in the affected eye
  • Sensitivity to light (photophobia)
  • Disorientation or difficulty moving around in familiar spaces

In more advanced stages, animals may exhibit aggressive behavior or irritability due to severe pain. It is important to remember that animals can adapt to vision loss without noticing it in early stages, so regular veterinary checkups are crucial to detect and treat this disease early.

Diagnosis of glaucoma

Diagnosis of glaucoma requires a thorough ophthalmologic evaluation. The most common tests include tonometry, which measures IOP and determines whether it is within normal limits, and ophthalmoscopy, to assess the condition of the optic nerve and retina. In some cases, gonioscopy may be performed to observe the iridocorneal angle, where the aqueous humor drains, and to determine if there is an obstruction in the flow of this fluid.

Early detection is essential to prevent irreversible damage to the optic nerve and loss of vision. Unfortunately, in many pets glaucoma presents acutely, with obvious symptoms, making intervention urgent.

Treatment of glaucoma in animals

Treatment of glaucoma in animals is aimed at reducing IOP and preventing further vision loss. There are two main approaches: medical treatment and surgical treatment.

  1. Medical treatment: In less severe cases, glaucoma can be managed with medications that reduce the production of aqueous humor or improve its drainage. These medications are usually eye drops, although systemic treatments are also available.
  2. Surgical treatment: When medical treatment is not sufficient, surgery is used. There are two main options:
    • Laser: Used to reduce the production of aqueous humor in the affected eye.
    • Drainage implants: Valves or tubes are placed to allow the aqueous humor to drain out of the eye, reducing internal pressure.

Both treatments are aimed at preventing the progression of glaucoma and preserving vision, although in advanced cases blindness may be inevitable.

Nutraceuticals in the management of glaucoma

Nutraceuticals play a complementary role in the management of glaucoma, helping to protect the optic nerve and improve ocular microcirculation.  Glauco+ from Dr+Vet by AndersenPets is an example of a supplement specially formulated for animals with glaucoma. It contains ingredients such as:

  • Ginkgo biloba, which improves ocular circulation and helps protect the optic nerve from ischemic damage.
  • Vaccinium myrtillus (bilberry), rich in antioxidants that neutralize free radicals and improve ocular blood flow.
  • Citicoline, a neuroprotectant that supports visual function and the central nervous system by protecting retinal ganglion cells from oxidative stress.

The use of these nutraceuticals can help slow the progression of glaucoma and improve the quality of life of affected pets, although they should always be combined with appropriate medical and surgical treatment.

Glaucoma prevention

Since glaucoma can be asymptomatic in its early stages, prevention is key. Genetically predisposed breeds, such as Cocker Spaniel, French Bulldog and Maltese Bichon, should undergo regular ophthalmologic checkups to detect any early signs of the disease. In some cases, veterinarians may prescribe preventive eye drops to lower IOP in pets with a family history of glaucoma.

In general, glaucoma is a disease that requires multidisciplinary management. The combination of medication, surgery and nutraceuticals may offer a better prognosis and preserve vision longer. It is essential that veterinarians watch for clinical signs and educate guardians on the importance of ophthalmologic examinations to detect glaucoma early.


Blog-amsterdam-ecvo-1200x675.png
21/Aug/2024

Cataracts are an eye condition that can affect both dogs and cats, and although more common in older animals, they can also develop in younger pets due to genetic factors or underlying diseases. Understanding how cataracts form, how they worsen over time and what treatment options are available is crucial to providing the best care for our pets.

What are Cataracts?

A cataract is a clouding of the crystalline lens, the clear lens of the eye that focuses light onto the retina. When the lens becomes opaque, a pet’s vision is impaired. Depending on the severity of the cataract, this can range from a slight decrease in vision to complete blindness.

Cataracts can affect one or both eyes, and their development can be gradual or rapid. Although they occur more frequently in dogs than in cats, both species can be affected.

How do cataracts form?

Cataracts develop due to a change in the structure of the lens proteins, which causes them to become opaque instead of transparent. This process can have several causes:

1. Genetic factors

In dogs, genetic cataracts are a common cause, especially in certain breeds. Breeds such as the Cocker Spaniel, Poodle, and Golden Retriever have a genetic predisposition to develop cataracts, often at an early age. In cats, although genetic cataracts are less common, certain breeds may also be predisposed.

2. Metabolic Diseases

Diabetes mellitus is a major cause of cataracts in dogs. In diabetic animals, elevated glucose levels in the lens cause a buildup of sorbitol, a substance that attracts water to the lens, leading to swelling and opacification. This type of cataract can develop rapidly, in a matter of weeks or months.

3. Trauma

Eye injuries, such as severe blows to the eye, can damage the lens and trigger the formation of a cataract. In these cases, the cataract usually develops in the affected eye and may be progressive.

4. Inflammatory Diseases

Uveitis, an inflammation of the eye that can be caused by infections or autoimmune diseases, can also induce cataract formation. Chronic inflammation can alter the composition of the ocular fluid, affecting the lens and favoring its opacification.

5. Age

Natural aging is a common cause of cataracts in older pets. Over time, biochemical changes in the lens cause proteins to clump together, forming opaque areas that make vision difficult.

Cataract Progression

The rate at which a cataract progresses can vary depending on the underlying cause. Some cataracts remain stable and do not significantly affect vision for years, while others may worsen rapidly.

In early stages, the cataract may be small and affect only a portion of the lens, causing a slight decrease in vision. Over time, the cataract may grow and cover more areas of the lens, resulting in more severe visual loss.

If left untreated, an advanced cataract can lead to additional complications, such as glaucoma. This occurs when clouding of the lens disrupts the circulation of aqueous humor, the fluid that nourishes and maintains eye pressure. The increased pressure inside the eye can damage the optic nerve, leading to permanent blindness if left untreated.

Cataract Treatments for Pets

Treatment for cataracts depends on the degree of visual impairment and the underlying cause. Currently, there are no medical treatments that can reverse a cataract, so intervention usually focuses on symptom management or surgery.

1. Medical Treatment

Although there are no medications that can eliminate a cataract once it has formed, medical treatment may be helpful in certain cases:

  • Anti-inflammatory drops and eye medication: In cases of cataracts related to ocular inflammation or uveitis, medications can be used to reduce inflammation and prevent further complications, such as glaucoma. Drops can also help control pain and irritation.
  • Control of underlying disease: In pets with diabetes-induced cataracts, it is critical to control blood glucose levels to prevent rapid progression of cataracts and other diabetes-related complications.
  • Use of nutraceuticals: Some nutraceuticals with antioxidants and vitamins beneficial to the eye can help slow the rate of cataract development. One of them would be Occulus+ from Dr+Vet by AndersenPets.

While medical treatments can alleviate symptoms or slow the progression, they do not eliminate cataracts, so the most effective option is still surgery.

2. Surgical Treatment

Surgery is the only definitive treatment to remove cataracts and restore vision. The most commonly used technique is phacoemulsification, similar to cataract surgery in humans.

Phacoemulsification procedure

During surgery, the veterinarian makes a small incision in the eye and uses ultrasound to fragment and remove the cloudy lens. An artificial intraocular lens is then placed in the eye to replace the natural lens, restoring the eye’s ability to focus.

Cataract surgery in pets has a high success rate, with most animals regaining functional vision. However, it is not without risks, such as infection, inflammation or postoperative complications, so proper follow-up after the procedure is important.

Requirements for Surgery

Not all animals are ideal candidates for surgery. The veterinarian will evaluate the pet’s general health, the condition of the eyes and whether there are other conditions, such as advanced glaucoma or retinal detachment, that could affect the success of the operation.

Conclusion

Cataracts in pets, although common, can significantly affect their quality of life if left untreated. From their formation to their progression, early diagnosis is critical to consider the most appropriate treatment options. Surgery is the most effective treatment to restore vision in animals with advanced cataracts, while medical management can help control symptoms and prevent complications. Regular veterinary follow-up is essential to ensure that our pets enjoy a full and healthy life, even in their old age.


blog-1-1200x627.png
03/Jun/2024

Dr+Vet will be one of the main sponsors of the next IVO Veterinary Ophthalmology Day: Practical Clinical Cases of the Anterior Segment!

This event will take place on June 15, 2024, from 9:00 to 18:15 at the IMO Auditorium in Barcelona, and will also be available in streaming for those who cannot attend in person.

About the Event

At Dr+Vet by AndersenPets, we are committed to the advancement of veterinary ophthalmology. Our participation in this prestigious event, which will feature high-level experts, reflects our continuous effort to contribute to the development of innovative solutions that improve ocular health and the quality of life of patients.

We cordially invite you to participate in this event specialized in Clinical Case Studies of the Anterior Segment. This event promises to be an enriching and educational experience for all animal health professionals interested in veterinary ophthalmology.

During this meeting, we will explore real clinical cases of the anterior segment of the eye, learn from experts in the field and share valuable insights with industry colleagues. We strongly believe in the importance of collaborating with colleagues committed to the advancement of veterinary medicine, thus strengthening our commitment to excellence in veterinary ophthalmology.

Preprogram

The program is subject to change and will be updated as details are finalized.

9:00 h – Registration and accreditation.
9:25 a.m. – Presentation of the day.
9:30 h – Session 1: Cases of palpebral and conjunctival pathology.
11:00 h – Coffee Break.
11:30 h – Session 2: Dry eye cases.
12:30 h – Session 3: Cases of infectious keratitis.
14:00 h – Lunch.
15:00 h – Session 4: Cases of non-infectious corneal pathology.
16:00 h – Session 5: Surgical cases of corneal and conjunctival pathology 1.
16:45 h – Coffee Break.
17:15 h – Session 6: Surgical cases of corneal and conjunctival pathology 2.
18:15 h – End of the day.

Speakers

The event will count with the participation of outstanding professionals in veterinary ophthalmology:

Kevin Arteaga, VMC Veterinari Medical Center (Hong Kong). Online participation.
Marti Cairó, Hospital Veterinari Canis (Girona).
Francisco Cantero, UAB (Bellaterra).
Miriam Caro, Hospital Veterinario Puchol (Madrid).
Laura Castilla, MEMVET (Palma de Mallorca). Online participation.
Victoria Espejo, Visualvet (Portugalete).
Marcos Izquierdo, IVEM (Valencia).
Monica de León, OFTALVET (Las Palmas de Gran Canaria).
Juan Maestro, MEMVET (Palma de Mallorca).
María Martinez, IVEM (Valencia).
Maribel Molina, Centre Veterinari El Passeig (Tarragona).
Laura Muñoz, OCULARVET (Madrid).
Carolina Naranjo, Lab IDEXX (Barcelona).
Raquel Prats, IVO (Ibiza).
Francisco Simó, IVO (Barcelona).
Maria Simó, IVO (Barcelona).
Esther Torrent, Lab IDEXX (Barcelona).
Maria Tohidi, IVO (Barcelona).

Registration

Registration is now open! You can register by filling out the form on the IVO Ophthalmology website. Don’t miss this unique opportunity to be part of an event that promises to be inspiring and educational.

Conclusion

We are proud to support these initiatives that promote knowledge and the advancement of veterinary ophthalmology. We look forward to connecting with all attendees and sharing our latest advances in treatments. see you soon!

We look forward to having you attend this unique and enriching day!


Mida-blog-bonica-gran-1200x675.png
22/May/2024

Veterinary ophthalmology is a complex and constantly evolving field, where research, innovation and collaboration are key to advancing pet eye care.

As passionate as we are about animal welfare and eye health, we are proud to announce our participation as sponsors of the 2024 European Congress of the European Association of Veterinary Ophthalmology (ECVO). This annual event is the epicenter of veterinary ophthalmology in Europe, bringing together the best specialists, researchers and practitioners in the field to share knowledge, present scientific advances and make meaningful connections.

Each year, ECVO hosts its annual congress in a major European city, providing a unique platform for the exchange of ideas, discussion of clinical cases and continuous learning. Over four intense days, the congress covers a wide range of topics related to veterinary ophthalmology, from the presentation of pioneering research to the discussion of innovative surgical techniques.

The 2024 program

The 2024 European Association of Veterinary Ophthalmology (ECVO) Congress promises to be exceptional, with a special focus on exotic animal ophthalmology. Under the theme “Ophthalmology of Exotic Animals,” the continuing education program and master class will explore the anatomical and physiological peculiarities of the eyes of reptiles, birds, rabbits and other exotic animals. Experts from Europe and the United States will share their knowledge on ophthalmological examination, husbandry and handling techniques of these animals. In addition, clinical cases, scientific research and advances in the field will be presented, providing a unique opportunity to learn from leaders in veterinary ophthalmology.

Our Participation in ECVO 2024

As leaders in the field of ophthalmic nutraceuticals, we at Dr+Vet are committed to the advancement of veterinary ophthalmology and the ocular care of our pets. During the congress, we will have the opportunity to present our latest advances in ophthalmological products, share our expertise and establish connections with other professionals in the industry. It is also a good opportunity to get a closer look at our products and we will be happy to introduce you to our range and discuss how they can benefit your patients!

See you at ECVO 2024!


blog-retinae-1200x675.png
21/May/2024

In recent years, there has been increasing interest in the use of nutraceuticals for retinal diseases.

Despite advances in pharmaceutical therapies, the protection of retinal neural tissue remains a significant challenge due to its limited regenerative capacity. In this context, research on the efficacy of nutraceuticals has become relevant, especially in the field of age-related macular degeneration (AMD). In this article, we will focus on the key ingredients present in Retinae, a nutraceutical product designed to maintain ocular health and prevent retinopathy.

The Retina

The retina is a highly specialized structure that lines the back of the eye and plays a crucial role in transmitting visual signals to the brain. Composed of several cell layers, the retina is highly vulnerable to damage caused by oxidative stress and inflammation, which are contributing factors in the development of diseases such as AMD. Maintaining the structural and functional integrity of the retina is critical to preserving visual health throughout life.

Retinae and RetinaeXL Ingredients

Tagetes erecta (Carotenoids – Lutein and Zeaxanthin):

Carotenoids, such as lutein and zeaxanthin, are plant pigments with antioxidant properties. Clinical studies, such as the Age-Related Eye Disease Study (AREDS), have shown that lutein and zeaxanthin may help protect the retina against oxidative damage and cellular degeneration associated with AMD. Supplementation with these carotenoids has shown significant benefits in preventing disease progression and preserving visual function.

Omega-3 Fatty Acids:

Omega-3 fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known for their anti-inflammatory and neuroprotective effects. Studies have shown that omega-3 supplementation can reduce retinal inflammation and neovascularization, two processes involved in the pathogenesis of AMD. In addition, omega-3 can modulate gene expression and improve retinal cell function, which contributes to the preservation of ocular health.

Vitamins (C, E, B [B6, B9, B12])

Antioxidant vitamins, such as vitamin C and vitamin E, play a crucial role in protecting the retina against oxidative stress. In addition, B vitamins, including B6, B9 and B12, are involved in the regulation of cellular metabolism and the prevention of neurodegeneration. Supplementation with these vitamins can help maintain retinal health and prevent the development of diseases such as diabetic retinopathy and AMD.

Minerals (Zinc and Copper)

Zinc and copper are essential minerals for cellular function and normal metabolism. Zinc supplementation can protect the retina against oxidative damage and cellular degeneration associated with AMD. In addition, copper plays an important role in regulating oxidative stress and inflammatory response, thus contributing to overall ocular health.

Lactoferrin

Lactoferrin, an iron-binding protein with antimicrobial and anti-inflammatory properties, may help protect the retina against damage caused by inflammation and oxidative stress. Studies have shown that lactoferrin can modulate the immune response and reduce the expression of proinflammatory cytokines.

Conclusion

Retinae’s unique composition, which includes a combination of carotenoids, omega-3 fatty acids, vitamins, minerals and lactoferrin, offers a comprehensive strategy for the maintenance of ocular health and the prevention of retinopathies. By addressing multiple mechanisms involved in the pathogenesis of diseases such as AMD, Retinae is a nutritional supplement that delivers all of these nutrients to the body and the retina.

Download the PDF for more detailed information on the composition of Retinae and bibliographic references to the studies mentioned.

More information about Rethinopathies in our Blog: https://drvet.pet/en/all-about-progressive-retinal-atrophy/


Miniatura-de-YouTube-Plan-de-Negocio-Sencillo-Moderno-Azul-1-1200x675.png
10/Apr/2024

On Wednesday 3rd April, Dr+Vet was honoured to welcome leading veterinary ophthalmologist Maria Simó for our first webinar on Keratoconjunctivitis Seca (KCS) in dogs. During this virtual event, María Simó shared her knowledge and experience in the diagnosis and treatment of this common but often underestimated eye disease. Today, we can finally announce that the full video, with subtitles in English (and other languages automatically), is available for viewing on our blog and our YouTube channel! Attached to this article, you will find the direct link to the video so you can access it and deepen the knowledge shared by María Simó.

About Maria Simó:

Maria Simó is a renowned veterinary ophthalmologist with a solid background and extensive experience in the field of veterinary ophthalmology. Graduated in Veterinary Medicine from the Autonomous University of Barcelona, María has completed several postgraduate courses and works as an ophthalmologist at the prestigious Instituto Veterinario Oftalmológico (IVO) in Barcelona.

Contenido del Webinar:

Maria Simó talked us through the basics of Keratoconjunctivitis Seca, from diagnostic methods to the most effective treatment options, exploring in detail how to approach this disease in a comprehensive way.

One of the main conclusions of the webinar was the importance of not relying solely on the Schirmer test to diagnose KCS. María Simó emphasised the need for a complete and detailed assessment, as well as the use of additional diagnostic tools for a correct diagnosis, as without all the information, ineffective treatments may be prescribed. She also talked about the importance of referring cases that do not resolve correctly in order to fully evaluate them.

 

We thank all participants for their support.

The webinar on Keratoconjunctivitis Seca with Maria Simó was a great success, and we would like to thank everyone who joined us for this educational event. We hope that this resource will be a valuable source of information for all veterinarians interested in veterinary ophthalmology. Feel free to check out the full video and share it with your colleagues.

Stay tuned to our social media and website for more information on future of Dr+Vet events and educational resources!


Spain-1200x675.png
25/Mar/2024

Keratoconjunctivitis Sicca (KCS), also known as “dry eye,” is a common ophthalmic condition in dogs and cats that affects the ocular surface, specifically the cornea and conjunctiva.

This disease results from the deficiency of some of the phases of the tear film, which leads to tear hyperosmolarity and, consequently, a series of ocular complications that can compromise the visual health of the animal.

The structure of the tear

To better understand KCS, it is important to know the three layers that make up the tear film and their functions:

  • Mucinous layer: This layer, the innermost, modifies the surface tension of the tear so that it adheres and distributes properly over the surface of the eye. Mucin is produced and secreted mainly in conjunctival goblet cells.
  • Aqueous layer: The intermediate layer, and the most abundant, hydrates the ocular surface and transports nutrients and oxygen essential for the metabolism of the cornea. It also acts as a flushing mechanism to remove debris and foreign bodies. This watery portion is produced and secreted in the main and accessory lacrimal glands.
  • Lipid layer: The outermost layer protects the aqueous layer from evaporation, allowing the tear to remain in the eye longer. In addition, it increases the surface tension of the tear, preventing overflow over the edge of the eyelid and lubricating the eyelids. This layer is produced and secreted mainly in the meibomian glands.

KCS classification

The KCS can be classified into two main types:

  • Qualitative KCS: It is produced by a pathological decrease in the lipid or mucoid components of the tear film, which makes it difficult for it to remain on the cornea, either due to excess evaporation or difficulty adhering. It is usually due to damage or inflammation in the meibomian glands or goblet cells of the conjunctiva.
  • Quantitative KCS: It is produced by a pathological decrease in the aqueous component of the tear film. It can have various causes, the most common being localized and chronic immune-mediated inflammation of the lacrimal gland. This is the most common form of KCS, and in most cases it progresses to a mixed form (quantitative and qualitative) over time.

What symptoms does it cause?

Symptoms of KCS may include mucosal exudate, conjunctival hyperemia, corneal opacity, neovascularization, corneal edema, and ulceration, among others. The diagnosis of KCS requires a thorough evaluation of the patient’s medical history and specific ophthalmological tests, such as the Schirmer Test, Fluorescein Test, and the Lysamine Green Test.

What treatment is used?

Treatment of KCS may include artificial tears, topical immunosuppressants, and surgical treatments, depending on the severity and underlying cause of the disease. Additionally, supplementation with specific nutraceuticals such as LACRIMALIS+ can help manage this disease, offering natural help to maintain pets’ eye health.

 

If your pet presents symptoms compatible with this disease, go to your trusted veterinarian for correct diagnosis and treatment.


ig-e1707836972627.png
04/Mar/2024

This event brings together thousands of professionals from the sector each year.

For the second consecutive year, Dr+Vet sponsors the Iberzoo-Propet AMVAC 2024 congress, the largest event on products and services related to pets, which will take place in Madrid from March 13 to 15.

During these days we will have the opportunity to connect with professionals from across the veterinary sector and share our latest innovations in veterinary nutraceuticals.

During this congress we will present a novelty in our ophthalmological range: RetinaeXL. The Retinae product has been part of the Dr+Vet catalog since its inception and now receives a new presentation adapted to larger breeds that suffer from hereditary idiopathic retinal degeneration.

Retinae XL: retina protection for XL dogs

The novelty of this congress is RetinaeXL. This product maintains the same formulation as Retinae but adapts its quantities to larger breeds, its recommended mode of use being 1 tablet per day for every 20kg (unlike Retinae which corresponds to 1 tablet per day for every 10kg).

Both Retinae and RetinaeXL provide nutrients to the retina, especially interesting in those breeds predisposed to retinopathies. Its main ingredients are Tagetes erecta (source of lutein and zeaxanthin) and omega 3 fatty acids that provide anti-inflammatory and antiangiogenic properties. These products also provide pets with Vitamins (C, E, B [B6, B9, B12]), Lactoferrin, Zinc and Copper.

Other product lines

In addition to our ophthalmological line, we will also be providing detailed information about our digestive and metabolic ranges, with the products Glyco, Flavum, Digestum and Colitum.

Iberzoo-Propet  serves as a platform to interact with professional colleagues and showcase our commitment to innovative veterinary care. Our team will be available to provide detailed information and answer any questions you may have about our products.

Stay tuned for updates and follow us on social media for more details as the event approaches. See you there!


foto-para-dentro-drvet-1200x600.jpg
30/Apr/2023

On April 27th, we had the pleasure of sponsoring an exciting webinar organized by the European Society of Veterinary Ophthalmology (ESVO) on the use of nutraceuticals in veterinary ophthalmic practice. The event, brought together leading professionals in the field and members interested in exploring this very relevant topic.

During the webinar, Dr. Teresa Peña, a renowned expert in veterinary ophthalmology and associate professor at the Autonomous University of Barcelona, gave a keynote lecture on the most commonly used ingredients in veterinary ophthalmology and their role in the treatment of various eye diseases in animals. Dr. Peña delved into the scientific evidence supporting the use of these nutraceuticals, as well as the recommended protocols for their application in daily practice. His vast experience and expertise in the field provided attendees with a clear and detailed view of how these products can benefit the ocular health of our veterinary patients.

The webinar was an invaluable opportunity to learn and share knowledge with colleagues from around the world. It also provided a platform for the exchange of ideas and experiences, thus strengthening our professional community.

If you missed the webinar or simply wish to relive it, we invite you to access the full recording available at the following link:

Don’t miss it!


foto-para-dentro-drvet-1200x600.jpg
03/Apr/2023

The webinar, which will take place on April 27, will address the most used ingredients in veterinary ophthalmology and their role in certain diseases, as well as the scientific evidence that supports them.

A webinar on nutraceuticals in veterinary ophthalmology will take place on Thursday, April 27 at 9:00 p.m. organized by the European Society of Veterinary Ophthalmology (ESVO), which is supported by Dr+Vet.

This webinar will address the most commonly used ingredients in veterinary ophthalmology and their role in certain diseases, as well as the scientific evidence that supports them and the recommended protocols. The webinar, which will be broadcast in English, is free for all ESVO members and for non-ESVO members, the price will be 30 euros.

The webinar will be given by ophthalmology specialist Teresa Peña, who graduated in Veterinary Medicine from the Autonomous University of Barcelona (UAB) in 1987 and received a doctorate from the same university in 1993 with an experimental study on penetrating corneal grafts in dogs.

Teresa Peña completed her ophthalmology residency at the European College of Veterinary Ophthalmologists (ECVO) in a program at North Carolina State University. Since 1988 she has worked in the Department of Medicine and Surgery of the Faculty of Veterinary Medicine (UAB) and currently she is an associate professor of ophthalmology and surgery, and head of the Ophthalmology service at the Veterinary Teaching Clinical Hospital (FHCV-UAB).

She has been a diplomate of the ECVO since 1999, member of the Examinations Committee between 2002-2010 and member of the Credentials Committee since 2010 (chair of the committee since 2016). She served on the board of directors of the European Society of Veterinary Ophthalmology (treasurer from 1999 to 2006, vice-president from 2006 to 2007 and president from 2007 to 2009).

Likewise, the expert co-directs a postgraduate course in veterinary ophthalmology, to obtain an intermediate degree, as well as residency programs to be part of the ECVO. Her work and research are dedicated to ophthalmology, especially corneal pathology and surgery, and uveitis and ocular injuries caused by infectious diseases.

 


Copyright by Boothmen Pharma 2023. All rights reserved.